NNZ-3006
NNZ-3006 has shown significant ability to reduce fat deposits in the animals without inducing insulin resistance or fluid retention.
|
Home | Corporate Profile | Technology & Research | Investors | Glossary | Contact Us |
NNZ-3006 has shown significant ability to reduce fat deposits in the animals without inducing insulin resistance or fluid retention.
|
Neuren has successfully expressed a naturally-occurring variant of human growth hormone. In multiple experiments in different animal models, NNZ-3006 has shown significant ability to reduce fat deposits in the animals without inducing insulin resistance or fluid retention — unwanted side effects that have limited the use of human growth hormone in adult populations. |
This product is targeted at approved adult growth hormone deficiency conditions as well as at metabolic disorders resulting in obesity, hyperlipidemia and diabetes. |
| ©2008 Neuren Pharmaceuticals Limited |